RTR-30 — 30mg | Research Use Only (RUO)

Description

A synthetic triple-receptor agonist peptide currently being investigated in controlled laboratory environments for its simultaneous interaction with multiple incretin and glucagon receptor signaling pathways.

For laboratory research use only. Not for human or animal consumption.

OVERVIEW

RTR-30 is a synthetic peptide studied in preclinical models for its interaction with three distinct receptor pathways: glucose-dependent insulinotropic polypeptide receptor (GIPR), glucagon-like peptide-1 receptor (GLP-1R), and glucagon receptor (GCGR). Laboratory research has examined its multi-receptor binding characteristics, comparative signaling profiles, and pathway co-activation dynamics under controlled experimental conditions.

Supplied as a lyophilized powder for analytical and experimental research applications.

PRODUCT SPECIFICATIONS

Compound: RTR-30
Quantity: 30 mg per vial
Form: Lyophilized powder
Purity: ≥98%
Storage: -20°C recommended, protect from light
CAS: 2381089-83-2

RESEARCH APPLICATIONS

– Triple-receptor co-activation signaling studies
– GIP/GLP-1/glucagon receptor binding analysis
– Multi-agonist comparative pathway research
– Incretin receptor selectivity modeling

RESEARCH USE ONLY

This product is intended strictly for laboratory research purposes. Not for human consumption. Not for veterinary use. Not for therapeutic or diagnostic applications. Not intended to treat, cure, or prevent any condition. Use is limited to qualified professionals in controlled laboratory environments.

Certificate of Analysis available upon request.